Avicanna exports cannabis flower to Switzerland

Executive Summary

• Avicanna Inc.'s majority-owned subsidiary, Santa Marta Golden Hemp SAS (SMGH), has successfully completed its first export of non-psychoactive, cannabidiol (CBD)-dominant cannabis flower to Switzerland.
• This milestone marks the 20th international market for the company's Aureus-branded products and the 23rd market for all Avicanna products, validating the company's ability to navigate complex international regulatory frameworks.
• The export follows 2024 infrastructure improvements and internal practice enhancements at SMGH, aimed at expanding the portfolio of premium organic flower to meet growing demand in Europe and Australia.

Key Details

• Transaction: First export of non-psychoactive CBD-dominant cannabis flower to Switzerland.
• Entity: Conducted through Avicanna Inc.'s majority-owned subsidiary, Santa Marta Golden Hemp SAS (SMGH).
• Product Varieties: The export included three proprietary cannabis varieties registered in Colombia.
• Strategic Context:
  • Marks the 20th international market for Aureus-branded products.
  • Marks the 23rd international market for all Avicanna products.
  • Demonstrates expertise in navigating complex regulatory processes for international commercialization.
• Operational Improvements: The export is attributed to improvements directed by the company in 2024, specifically:
  • Enhanced internal practices.
  • Upgraded local infrastructure at SMGH.
  • Expansion of the Aureus-branded product portfolio with premium organic flower.
• Current Production: The company is currently producing a range of proprietary and premium genetics, including CBD, cannabigerol (CBG), and tetrahydrocannabinol (THC), targeting medical cannabis markets in Europe and Australia.
• Compliance: Avicanna states that operations are carried out in compliance with all applicable laws in the jurisdictions where it operates.

Notable Quotes

• No direct quotes from executives were included in the provided text.